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1. Introduction 
Acetylcholinesterase (EC 3.1.1.7) has been the 
subject of many kinetic studies [2]. However, neither 
the kinetic mechanisms nor the ammo acid residues 
involved in substrate binding with the exception of 
the activated serine residue [2] could be elucidated 
completely from these studies. From kinetic and 
chemical modification data histidine [3] and tyrosine 
[4] residues have been proposed to have functional 
roles in the catalytic mechanism and are located near 
or within the active centre of the enzyme. 
A carboxyl residue different from that within the 
anionic part of the active centre was localized [5] 
within one of the peripheric anionic sites [2]. But 
nothing is known about the function of the basic 
amino acids like lysine and arginine. Since lysine as 
well as arginine are able to bind negatively charged 
substrates and also stabilize conformations we have 
investigated the role of basic amino acids in the cata- 
lytical mechanism of acetylcholinesterase by chem- 
ical modification of the arginine residues with both 
butanedione and phenylglyoxal, which are arginine- 
specific reagents. The chemical modifications were 
also carried out in the presence of the effecters 
N-methylpyridinium-2-aldoxime iodide, flaxedil, 
edrophonium, hexamethonium and decamethonium, 
because Changeux [6] observed an activation effect 
of peripheric bound ligands, probably caused by 
allosteric effects [4,7]. The location of the modified 
arginine residues and their participation in the cata- 
lytic mechanism is discussed. 
* This work has been described in a preliminary report [ 1 ] 
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2. Experimental 
Acetylcholinesterase was prepared from the elec- 
tric organs of Tolpedo califomica delivered deep 
frozen by the Pacific Biomarine labs, Venice, 
California [8]. The ‘11 S’ or tryptic species was fur- 
ther purified by a single step affinity chromatography 
using the strong inhibitor phenyltrimethylammonium 
bromide coupled to Sepharose 4B [9]. A highly 
active enzyme preparation (specific activity about 
3000 I. U./mg) containing 5% impurity was obtained. 
Specific activity was measured at 25’C in 50 mM 
phosphate buffer, pH 7.2, with acetylthiocholine 
(500 PM) as the substrate according to [lo]. Protein 
concentration was determined by the Folin method 
using serum albumin as standard. The amino acids 
were hydrolyzed in 6 M HCl for 24 h at 1lO’C and 
analyzed on the Biotronik amino acid analyzer using 
both short and long columns according to [l 11. 
Chemical modification by butanedione or by phenyl- 
glyoxal was carried out at 25°C in phosphate-borate 
buffer (5 mM phosphate, 25 mM borate, 50 mM 
sodium chloride), pH 7.0, at a protein concentration 
in the incubation mixture of lo-20 pg/ml. Enzy- 
matic activity was measured at various intervals under 
standard test conditions by the addition of 5 ~1 of 
the incubation mixture to the standard assay. Neither 
butanedione nor phenylglyoxal affected the enzymatic 
activity under standard assay conditions. 
Butanedione (freshly distilled before use), phenyl- 
glyoxal, N-methylpyridinium-2-aldoxime iodide and 
decamethonium bromide were obtained from Fluka 
(Buchs, Switzerland). Acetylthiocholine and dithio- 
nitrobenzoic acid were purchased from Serva 
(Heidelberg, FRG), flaxedil from Bohringer 
(Ingelheim, FRG), and hexamethonium bromide 
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from Sigma (St Louis, USA). Buffer substances, all 
of analytical grade, were products of E. Merck 
(Darmstadt, FRG). Edrophonium bromide was syn- 
thesized by quaternization of NJVdimethyl-m-amino- 
phenol (Fluka, Buchs, Switzerland) with ethyl bro- 
mide (Merck) in acetone, according to [ 121. 
The circular dichroism spectra of native and modi- 
fied acetylcholinesterase (dissolved in phosphate- 
borate buffer pH 7.0) were obtained with a Cary 60 
spectrophotometer (Varian, Darmstadt, FRG) 
equipped with a CD-device (6002). Ultracentrifuga- 
tion analyses were performed in an analytical ultra- 
centrifuge Spinco E from Beckman Instruments 
(Miinchen, FRG) at 20°C and 60 000 rev./min in 
phosphate-borate buffer pH 7.0, also used for the 
chemical modification. The protein concentration 
was 0.2-0.4 mg/ml. 
3. Results 
Whereas phenylglyoxal has almost no effect on 
enzyme activity during the period of incubation, 
butanedione inactivates the enzyme over the same 
time period. The time course of this inactivation is 
presented in fig. 1. 
Butadione inactivation is concentration-dependent. 
After 90 min, the enzyme is inactivated to about 80% 
in the presence of 4.6 mM butanedione. Longer incu- 
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Fig.1. Time course of the loss of enzymatic activity of acetyl- 
cholinesterase after incubation with butanedione (0, 1.2 mM; 
a, 2.3 mM; q ,4.6 mM; X, 6.9 mM). Y, is the initial rate of 
the control, v that of the modified enzyme. 
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bation, even in the presence of higher concentrations 
of butanedione, does not cause complete inactivation 
of the enzyme and a residual activity of S--IO% 
always remains. The inactivation, however, is not 
reversible. Dialysis against butanedione- and borate- 
free buffer, dilution of samples with buffer, free of 
borate and butanedione, or incubation with 0.1 M 
NHZCO could not restore the enzymatic activity. 
Incubation with butanedione in the presence of 
effecters, as shown in fig.2, demonstrates that 
butanedione acts specifically because N-methyl- 
pyridinium-2aldoxime iodide and flaxedil protect 
the enzyme almost completely against inactivation by 
this reagent, whereas the other effecters studied have 
weaker but significant effects. Edrophonium which 
binds specifically with a high affinity to the active 
centre, protects to a greater extent than the bifunc- 
tional compounds hexarnethonium and decametho- 
nium which show the weakest protection. 
The amino acid analyses of the native enzyme pro- 
tein and the samples treated with butanedione and 
phenylglyoxal in the absence or presence of N-methyl- 
pyridinium-2-aldoxime iodide (table 1) reveal that 
only arginine residues are modified. Phenylglyoxal 
modifies three arginine residues with a maximum 
activity loss of 15%. Butanedione modifies four 
arginine residues out of a possible thirtyone with 
IO 20 30 LO 50 60 70 
Time(mmJ 
Fig.2. Influence of effecters on the time course of the inacti- 
vation of acetylcholinesterase by butanedione (5.6 mM) Incu- 
bation in the presence of edrophonium (o), hexamethonium 
(a), decamethonium (A), flaxedil (A) andN-methylpyridi- 
nium-2aldoxime iodide (0). Concentration of the effecters 
in each case 100 PM. X is the control in the absence of effec- 
tor. Y, is the initial rate of the control, u that of the enzyme 
incubated with butanedione and effector. 
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Table 1 
Arginine content of acetylcholinesterase after modification with butanedione 
and phenylglyoxal 
Sample mol Arg/mol Enzymatic 
polypeptide activity 
Chain (%o) 
Control 
+ Butanedione, 5,6 mM 
+ Butanedione, 5.6 mM, and 
31 f 0.4 100 
27.3 f 0.2 21 
N-phenylpyridinium-2aldoxime 
iodide, 100 MM 28.1 t 0.4 98 
+ Pheny~lyox~, 5 mM 28.2 k 0.6 83 
Amino acid analysis was performed (six analyses in each case) after incubation 
during 90 min under the‘same conditions as in fig.2, followed by dialysis against 
phosphate-borate buffer, pH 7.0 (two changes, 12 h) and distilled water (6 h) 
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more than 70% loss of activity. In the presence of 
~-m~~ylpy~d~ium-2-aldo~e iodide, however, 
only three arginine residues without inactivation are 
modified, as was obtained with phenylglyoxal as the 
chemical modifier. From this it can be concluded 
that N-methylpyridinium-2-aldoxime odide protects 
one arginine against modification and that this argi- 
nine residue is essential for the enzymatic activity. 
The Michaelis constant of the enzyme for acetyl- 
thiocholine remains almost unchanged after modifica- 
tion (60 PM compared to 50 PM for the unmodified 
enzyme), but I’,, decreases significantly from 
3030 I.U./mg to 150 I.U./mg. However, sedimenta- 
tion analysis hows that modification by butanedione 
changes 20,w from IO.5 S for the native enzyme to 
10.0 S, indicating a small effect on the conformation. 
Incubation with butanedione in the presence of 
N-methylpyridinium-2-aldoxime iodide has less effect 
@20 w 10.3 S). The decrease of the enzymatic activity 
cat&d by butanedione modification is accompanied 
by a decrease of circular dichroism amplitude at 
229 nm. The data obtained from both, circular 
dichroism measurements and the sedimentation anal- 
ysis indicate a conformational change caused by the 
modulation of one arginine residue which can be 
protected by ~-methylpyridinium-2-aldox~e iodide 
and flaxedil, since the modification in the presence 
of N-methylpyridinium-2-aldoxime odide causes only 
a very small reduction of the amplitude at 229 nm. 
4. Discussion 
N-Methylpyridinium-2-aldoxime iodide and 
flaxedil protect he enzyme against inactivation by 
butanedione, drophonium - althou~ a very specific 
ligand for the active centre - is less effective, but 
affords better protection than either hexamethonium 
or decamethonium. 
The protection effect might be due to one or both 
of the following reasons: (a) Steric hindrance. If the 
ligand is bound at the site where modi~cation occurs, 
less inactivation should be observed. (b) If the lig- 
and L induces a conformational change of the 
enzyme E such that the reactive residue becomes 
inaccessible, the reaction can be prevented according 
to the equ~bri~ of E + L * EL. 
The effects of ~-methylpy~d~ium-2-aldox~e 
iodide and flaxedil can be ascribed to both or either 
of these reasons, but a conformational change is most 
probable. When we consider the effects of all effec- 
tors used, their one common factor (edrophonium 
1131, hex~e~o~urn and de~~e~o~urn [161, 
flaxedil [6,14] and ~-methylpyrid~ium-2-~dox~e 
iodide [ 14-161) is that they bind to the anionic part 
of the active centre in the presence of high ionic 
strength buffers used in our experiments. For this 
reason, a possible conformational change must be 
produced by binding to the anionic part of the active 
centre. This is indicated not only by sedimentation 
analysis,but also by circular dichroism measurements. 
But the binding of a quaternary ammonium group 
alone, like those of decamethonium, is not sufficient 
to achieve the conformational change which is neces- 
sary to induce the protection of the arginine residue. 
The three ligands with the best protection against 
inactivation, flaxedil, N-methylpyridinium-2-aldoxime 
iodide and edrophonium, all possess an aromatic ring. 
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Therefore, both ionic and hydrophobic interactions 
have to act together to produce a conformational 
change necessary for complete protection of the argi- 
nine residues in the active centre. It could be imag- 
ined that these compounds which contain both ionic 
as well as hydrophobic moieties act as a %lamp’ 
which distorts the conformation. In this connection, 
hydrophobic areas which can interact with aromatic 
ligands have been shown to be near to the anionic part 
of the active centre of the electric eel enzyme [ 171. 
Summarizing our results, we can conclude that 
one of the four modified arginine residues near the 
anionic part of the active centre is protected against 
modification by a confonnational change induced by 
binding of an aromatic compound to that site. Per- 
haps the inability of phenylglyoxal to yield the same 
result as butanedione is also caused by this effect. 
Modification of this arginine residue has an effect on 
the enzyme conformation and seems to influence the 
enzymatic activity only by this conformational 
change and not by direct influence on the catalytic 
mechanism. 
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